| Cozaar Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Cozaar 25 mg | tablet | oral | 1.0 each | OTC |
| Cozaar 100 mg | tablet | oral | 1.0 each | OTC |
| Cozaar 50 mg | tablet | oral | 1.0 each | OTC |
Posted by midwestern 11 months ago
At first everything seemed ok with Cozaar (50 mg). My doc put me on this since she said it has the least side effects. I ha...
Posted by meadow2345 12 months ago
I've been on cozaar for 4 years without any problems. I'm still no sure how my blood pressure became high, it was fine up ti...
Posted by rahimsaid about 1 year ago
I was switched from Natrilix SR to Coversyl. After about two days on Coversyl, I developed a persistent dry cough. I went b...
Carmel biotech firm inks Merck deal - Indianapolis Star
Merck's top products include Singulair for asthma, Cozaar and Hyzaar for hypertension, Fosamax for osteoporosis and Zocor for cholesterol, according to ...
Thu Mar 06 16:28:47 -0500 2008
Merck Pays More Than $400 Million to Settle Federal, State ... - PharmaLive.com (press release)
Merck employed four schemes to grab or maintain market share for drugs including Vioxx(R), Zocor(R), Cozaar(R), Fosamax(R), Maxalt(R), and Singulair(R), ...
Thu Feb 07 15:19:07 -0500 2008
Carmel biotech firm inks Merck deal - Indianapolis Star
Merck's top products include Singulair for asthma, Cozaar and Hyzaar for hypertension, Fosamax for osteoporosis and Zocor for cholesterol, according to ...
Thu Mar 06 16:28:47 -0500 2008
losartan potassium - The potassium salt form of losartan, a non-peptide angiotensin II antagonist with antihypertensive activity. Losartan potassium selectively and competitively blocks the binding of angiotensin II to the angiotensin I (AT1) receptor. Angiotensin II, formed from angiotensin I by angiotensin-converting enzyme (ACE), stimulates the adrenal cortex to synthesize and secrete aldosterone, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. Losartan potassium, by blocking the binding of angiotensin II to the AT 1 receptor, promotes vasodilatation and decreases the effects of aldosterone.